Abstract

Characterization of the circulating metabolites for a new chemical entity in humans is essential for safety assessment, an understanding of their contributions to pharmacologic activities, and their potential involvement in drug-drug interactions (DDI). This review examines the abundance of metabolites relative to the total parent drug (M/P ratio) from 125 drugs in relation to their structural and physicochemical characteristics, lipoidal permeability, protein binding, and fractional formation from parent (f_m). Our analysis suggests that f_m is the major determinant of total drug M/P ratio for amine, alcohol, N- and S-oxide, and carboxylic acid metabolites. Passage from the hepatocyte to systemic circulation does not appear to be limiting owing to the vast majority of metabolites formed being relatively lipid permeable. In some cases, active transport plays an important role in this process (e.g., carboxylic acid metabolites). Differences in total parent drug clearance and metabolite clearance are attenuated by the reduction in lipophilicty introduced by the metabolic step and resultant compensatory changes in unbound clearance and protein binding. A small sub-class of these drugs (e.g. terfenadine) are unintentional pro-drugs with very high parent drug clearance resulting in very high M/P ratios. In contrast, arenol metabolites show a more complex relationship with f_m due largely to the new metabolic routes (conjugation) available to the metabolite compared to the parent drug molecule. For these metabolites, a more thorough understanding of the elimination clearance of the metabolite is critical to discern the likelihood of whether the phenol will constitute a major circulating metabolite.